Fluorescence diagnosis and photodynamic therapy in dermatology

Medical Laser Application

Volumn 18, Issue 1, 2003, Pages 47-56

  Bäumler, Wolfgang ^a,b   Abels, Christoph ^a   Szeimies, Rolf Markus ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

5 aminolevulinic acid; Dermatology; Fluorescence diagnosis; Photodynamic therapy; Skin tumours

Indexed keywords

BIOPSY; BIOSYNTHESIS; DERMATOLOGY; FLUORESCENCE; ONCOLOGY; TUMORS;

REGISTRATION PROCESSES;

PHOTODYNAMIC THERAPY;

5 AMINOLEVULINATE SYNTHASE; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; PHOTOFRIN; POLYURETHAN; UNCLASSIFIED DRUG;

ACNE VULGARIS; ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BOWEN DISEASE; CHEMOSURGERY; CONDYLOMA; DRUG APPROVAL; DRUG INDICATION; ESTHETIC SURGERY; FLUORESCENCE; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MORPHEA; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PSORIASIS; REVIEW; SCAR; SEBACEOUS NEVUS; SKIN BIOPSY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS;

EID: 0037397667     PISSN: 16151615     EISSN: None     Source Type: Journal    
DOI: 10.1078/1615-1615-00087     Document Type: Review

References (34)

1. ABELS C: Wirkmechanismus der photodynamischen Therapie. In: SZEIMIES RM, JOCHAM D, LANDTHALER M (eds): Klinische Fluoreszenzdiagnostik und Photodynamische Therapie. Blackwell, Berlin Wien pp 59-68 (2003)
2. ACKERMANN G, ABELS C, BÄUMLER W, LANGER S, LANDTHALER M, LANG EW, SZEIMIES RM: Simulations on the selectivity of 5-aminolevulinic acid-induced fluorescence in vivo. J Photochem Photobiol B: Biol 47: 121-128 (1998)
3. ANDERSON RR, PARRISH JA: The optics of human skin. J Invest Dermatol 77: 13-19 (1981)
4. BAUMGARTNER R, HUBER RM, SCHULZ H, STEPP H, RICK K, GAMARRA F, LEBERIG A, ROTH C: Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J Photochem Photobiol B: Biol 36: 169-174 (1996)
5. BRETSCHKO E, SZEIMIES RM, LANDTHALER M, LEE G: Topical 5-Aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Evaluation of stratum corneum permeability in vitro. J Contr Release 42: 203-208 (1996)
6. FIGGE FHJ, WEILAND GS, MANGANIELLO CJ: Cancer detection and therapy, affinity of neoplastic, embryonic and traumatized tissue for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 68: 640-641 (1948)
7. FRITSCH C, BECKER-WEGERICH PM, MENKE H, RUZICKA T, GOERZ G, OLBRISCH RR: Successful surgery of multiple recurrent basal cell carcinoma guided by photodynamic diagnosis. Aesth Plast Surg 21: 437-439 (1997)
8. HEYERDAHL H, WANG I, LIU DL, BERG R, ANDERSON-ENGELS S, PENG Q, MOAN J, SVANBERG S, SVANBERG K: Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumour and normal tissue. Cancer Lett 112: 225-231 (1997)
9. JEFFES EW, McCULLOUGH JL, WEINSTEIN GD, FERGIN PE, NELSON JS, SHULL TF, SIMPSON KR, BUKATY LM, HOFFMAN WL, FONG NL: Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. Arch Dermatol 133: 727-732 (1997)
10. JORI G: Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J Photochem Photobiol B: Biol 36: 87-93 (1996)
11. KARRER S, BÄUMLER W, ABELS C, HOHENLEUTNER U, LANDTHALER M, SZEIMIES RM: Long pulse dye laser for photodynamic therapy - investigations in vitro and in vivo. Lasers Surg Med 25: 51-59 (1999)
12. KENNEDY JC, POTTIER RH: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B: Biol 14: 275-292 (1992)
13. KRIEGMAIR M, BAUMGARTNER R, KNÜCHEL R, STEPP H, HOFSTÄDTER F, HOFSTETTER A: Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155: 105-110 (1996)
14. KRIEGMAIR M, ZAAK D, KNÜCHEL R, BAUMGARTNER R, HOFSTETTER A: 5-aminolevulinic acid-induced fluorescence endoscopy for the detection of lower urinary tract tumors. Urol Int 63: 27-31 (1999)
15. LAM S, HUNG JY, KENNEDY SM, LERICHE JC, VEDAL S, NELEMS B, MACAULAY CE, PALCIC B: Detection of dysplasia and carcinoma in situ by ratio fluorometry. Am Rev Respir Dis 146: 1458-1461 (1992)
16. LANGER S, ABELS C, BOTZLAR A, PAHERNIK S, RICK K, SZEIMIES RM, GOETZ AE: Active and higher intracellular uptake of 5-aminolevulinic acid in tumours may be inhibited by glycine. J Invest Dermatol 112: 723-728 (1999)
17. LIPSON RL, PRATT JH, BALDES EJ: Hematoporphyrin derivative for detection of cervical cancer. Obstet Gynecol 24: 78 (1964)
18. Lui H: Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update. Semin Oncol 21: 11-14 (1994)
19. MESSMANN H, KNÜCHEL R, BÄUMLER W, HOLSTEGE A, SCHÖLMERICH J: Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Gastrointest Endosc 49: 97-101 (1999)
20. MOAN J, IANI V, MA L: Choice of proper wavelength for photochemotherapy proceedings of photochemotherapy and other modalities. Proc SPIE 2625: 544-549 (1996)
21. MOAN J: Porphyrin photosensitization and phototherapy. Photochem Photobiol 43: 681-690 (1986)
22. MORTON CA, WHITEHURST C, McCOLL JH, MOORE JV, MACKIE RM: Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch Dermatol 137: 319-324 (2001)
23. MORTON CA, WHITEHURST C, MOSELEY H, McCOLL JH, MOORE JV, MACKIE RM: Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 135: 766-771 (1996)
24. POLICARD A: Etude sur les aspects offerts par des tumeurs experimentales examinees a la lumiere de Wood. C R Soc Biol 91: 1423-1428 (1924)
25. ROGERS DW, LANZAFAME RJ, BLACKMAN J, NAIM JO, HERRERA HR, HINSHAW JR: Methods for the endoscopic photographic and visual detection of helium cadmium laser-induced fluorescence of Photofrin II. Lasers Surg Med 10: 45-51 (1990)
26. STUMMER W, STOCKER S, WAGNER S, STEPP H, FRITSCH C, GOETZ C, GOETZ AE, KIEFMANN R, REULEN HJ: Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42: 518-526 (1998)
27. SZEIMIES RM, DRÄGER J, ABELS C, LANDTHALER M: History of photodynamic therapy in dermatology, In: CALZAVARA-PINTON PG, SZEIMIES RM, ORTEL B (eds): Photodynamic therapy and fluorescence diagnosis in dermatology. Elsevier Science B.V. Amsterdam pp 3-15 (2001)
28. SZEIMIES RM, KARRER S, ABELS C, LANDTHALER M, ELMETS CA: Photodynamic therapy in dermatology. In: KRUTMANN J, HÖNIGSMANN H, ELMETS CA, BERGSTRESSER PR (eds): Dermatological phototherapy and photodiagnostic methods. Springer, Berlin Heidelberg New York pp 209-247 (2001)
29. SZEIMIES RM, KARRER S, RADAKOVIC-FIJAN S, TANEW A, CALZAVARA-PINTON PG, ZANE C, SIDOROFF A, HEMPEL M, ULRICH J, PROEBSTLE T, MEFFERT H, MULDER M, SALOMON D, DITTMAR HC, BAUER JW, KERNLAND K, BRAATHEN L: Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 47: 258-262 (2002)
30. SZEIMIES RM, KARRER S, SAUERWALD A, LANDTHALER M: Topical photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic keratoses: a first clinical study. Dermatology 192: 246-251 (1996)
31. SZEIMIES RM, LANDTHALER M, KARRER S: Non-oncologic indications for ALA-PDT. J Dermatol Treat 13 (Suppl 1): S13-S18 (2002)
32. SZEIMIES RM, SASSY T, LANDTHALER M: Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol 59: 73-76 (1994)
33. WANG I, BENDSOE N, KLINTEBERG CAF, ENEJDER AMK, ANDERSSON-ENGELS S, SVANBERG S, SVANBERG K: Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 144: 832-840 (2001)
34. WOLF P, RIEGER E, KERL H: Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 28: 17-21 (1993)